London, United Kingdom

William Mahy

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucl Business Plc. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Mahy. Retrieved from https://idiyas.com/inventor/william-mahy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: William Mahy: Innovator in Pharmaceutical Compounds

Introduction

William Mahy is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors of Notum. His work is crucial for advancing treatments for diseases that can be ameliorated through this inhibition.

Latest Patents

William Mahy holds a patent for "Compounds which are inhibitors of Notum." This compound is designed for use in the treatment of diseases that benefit from the inhibition of Notum, represented by a specific formula. His innovative approach has the potential to impact therapeutic strategies significantly.

Career Highlights

Currently, William Mahy is associated with UCL Business Plc, where he continues to explore and develop his research in pharmaceutical compounds. His dedication to innovation in this field is evident through his patent and ongoing research efforts.

Collaborations

William has collaborated with esteemed colleagues, including Edith Yvonne Jones and Elliott D Bayle. These partnerships enhance the research environment and contribute to the advancement of their collective work.

Conclusion

William Mahy is a distinguished inventor whose work in pharmaceutical compounds exemplifies innovation in the treatment of diseases. His contributions are vital to the ongoing development of effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…